Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT01214733
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>/=18 years of age
* Moderate to severe rheumatoid arthritis of more than 6 months duration upon entering the study
* Patients successfully completed studies WA17823 and WA18696 in South Africa
* Body weight \<150 kg
Exclusion Criteria:
* Patients who have withdrawn from studies WA17823 and WA18696 are not eligible to participate in this study Treatment with any investigational agent since last administration of study drug in studies WA17823 and WA18696
* Previous treatment with any cell depleting therapies
* Treatment with intravenous gamma globulin, plasmapheresis or Prosorba(TM) column since the last administration of study drug in studies WA17823 and WA18696
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01214733
Study Brief:
Protocol Section:
NCT01214733